Cullinan Therapeutics, Inc. (CGEM)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$12.89
—
Mkt Cap $783.81M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (13 analysts)
$30.43
Range $26.00 – $38.00
Implied Upside
+136.2%
Consensus $30.43 vs current $12.89